Site 9280
Site 9280
Portland, Oregon, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Epstein-Barr virus infection, Esophageal Neoplasms, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Tumor Virus Infections, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, diffuse large B-cell lymphoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal cancer, esophageal disorder, follicular lymphoma, head and neck squamous cell carcinoma, immune system disorder, immunoproliferative disorder, intestinal disorder, lung disorder, lung neoplasm, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin squamous cell carcinoma, squamous cell carcinoma, triple-negative breast carcinoma, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-10-16 | NCT05565417 |